RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $244,995 | -7.8% | 14,741 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $265,839 | +0.7% | 14,216 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $264,112 | +7.3% | 14,393 | +15.8% | 0.00% | 0.0% |
| Q4 2022 | $246,154 | -17.1% | 12,432 | +0.7% | 0.00% | 0.0% |
| Q3 2022 | $297,000 | +33.8% | 12,344 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $222,000 | -4.7% | 12,169 | +15.0% | 0.00% | +100.0% |
| Q1 2022 | $233,000 | -44.0% | 10,580 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $416,000 | +14.9% | 11,324 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $362,000 | +13.1% | 11,662 | +15.8% | 0.00% | +100.0% |
| Q2 2021 | $320,000 | +125.4% | 10,070 | +57.5% | 0.00% | – |
| Q1 2021 | $142,000 | +12.7% | 6,395 | +0.3% | 0.00% | – |
| Q4 2020 | $126,000 | -40.3% | 6,378 | -2.8% | 0.00% | -100.0% |
| Q3 2020 | $211,000 | +8.2% | 6,560 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $195,000 | +786.4% | 6,710 | +537.8% | 0.00% | – |
| Q1 2020 | $22,000 | -18.5% | 1,052 | +8.0% | 0.00% | – |
| Q4 2019 | $27,000 | – | 974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |